SEATTLE--(BUSINESS WIRE)--Geospiza, Inc., the market-leading developer of genetic analysis software, today announced that Dr. Bruce Montgomery was appointed to Geospiza’s Board of Directors. Dr. Montgomery has over 20 years of experience in pharmaceutical and biotechnology management as well as 10 years in academic research and medicine. He recently served as Senior Vice President of Respiratory Therapeutics at Gilead Sciences and was a member of the Gilead Executive Committee. Previously, he had founded and served as Chief Executive Officer of Corus Pharmaceuticals until its sale to Gilead for over $365 million in 2006. Prior to founding Corus, Dr. Montgomery was Executive Vice President of Research & Development for PathoGenesis. Earlier in his career, Dr. Montgomery led new product development at Genentech and taught medicine at the University of California – San Francisco.
